Selected research
Industry Growth & Trends
Global Calming and Sleeping Industry Growth and Trends Forecast to 2032
Market perspective
The global Calming and Sleeping market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Calming and Sleeping include Teva Pharmaceutical, Johnson & Johnson, Eli Lilly, AstraZeneca, Sunovion Pharmaceuticals, Roscoe Medical, Durect, Collegium Pharmaceutical and Cara Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Calming and Sleeping market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Calming and Sleeping market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Calming and Sleeping market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Calming and Sleeping.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Calming and Sleeping market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Calming and Sleeping Market by Company
Teva Pharmaceutical
Johnson & Johnson
Eli Lilly
AstraZeneca
Sunovion Pharmaceuticals
Roscoe Medical
Durect
Collegium Pharmaceutical
Cara Therapeutics
Acura Pharmaceuticals
Calming and Sleeping Segment by Type
Medications
Sleep Laboratories
Sleep Apnea Devices
Mattresses and Pillows
Prescriptions
Over-The-Counter (OTC)
Calming and Sleeping Segment by Application
Restless Leg Syndrome (RLS)
Narcolepsy
Sleepwalking
Bruxism
Insomnia
Sleep apnea
Calming and Sleeping Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming and Sleeping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Calming and Sleeping and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming and Sleeping.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Calming and Sleeping manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Calming and Sleeping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medications
- Sleep Laboratories
- Sleep Apnea Devices
- Mattresses and Pillows
- Prescriptions
- Over-The-Counter (OTC)
Applications
- Restless Leg Syndrome (RLS)
- Narcolepsy
- Sleepwalking
- Bruxism
- Insomnia
- Sleep apnea
Companies covered
- Teva Pharmaceutical
- Johnson & Johnson
- Eli Lilly
- AstraZeneca
- Sunovion Pharmaceuticals
- Roscoe Medical
- Durect
- Collegium Pharmaceutical
- Cara Therapeutics
- Acura Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Calming and Sleeping Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Calming and Sleeping Sales Estimates and Forecasts (2021-2032)
- 1.3 Calming and Sleeping Market by Type
- 1.3.1 Medications
- 1.3.2 Sleep Laboratories
- 1.3.3 Sleep Apnea Devices
- 1.3.4 Mattresses and Pillows
- 1.3.5 Prescriptions
- 1.3.6 Over-The-Counter (OTC)
- 1.4 Global Calming and Sleeping Market Size by Type
- 1.4.1 Global Calming and Sleeping Market Size Overview by Type (2021-2032)
- 1.4.2 Global Calming and Sleeping Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Calming and Sleeping Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Calming and Sleeping Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Calming and Sleeping Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Calming and Sleeping Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Calming and Sleeping Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Calming and Sleeping Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Calming and Sleeping Industry Trends
- 2.2 Calming and Sleeping Industry Drivers
- 2.3 Calming and Sleeping Industry Opportunities and Challenges
- 2.4 Calming and Sleeping Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Calming and Sleeping Revenue (2021-2026)
- 3.2 Global Top Players by Calming and Sleeping Sales (2021-2026)
- 3.3 Global Top Players by Calming and Sleeping Price (2021-2026)
- 3.4 Global Calming and Sleeping Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Calming and Sleeping Major Company Production Sites & Headquarters
- 3.6 Global Calming and Sleeping Company, Product Type & Application
- 3.7 Global Calming and Sleeping Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Calming and Sleeping Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Calming and Sleeping Players Market Share by Revenue in 2025
- 3.8.3 2025 Calming and Sleeping Tier 1, Tier 2, and Tier 3
4 Calming and Sleeping Regional Status and Outlook
- 4.1 Global Calming and Sleeping Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Calming and Sleeping Historic Market Size by Region
- 4.2.1 Global Calming and Sleeping Sales in Volume by Region (2021-2026)
- 4.2.2 Global Calming and Sleeping Sales in Value by Region (2021-2026)
- 4.2.3 Global Calming and Sleeping Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Calming and Sleeping Forecasted Market Size by Region
- 4.3.1 Global Calming and Sleeping Sales in Volume by Region (2027-2032)
- 4.3.2 Global Calming and Sleeping Sales in Value by Region (2027-2032)
- 4.3.3 Global Calming and Sleeping Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Calming and Sleeping by Application
- 5.1 Calming and Sleeping Market by Application
- 5.1.1 Restless Leg Syndrome (RLS)
- 5.1.2 Narcolepsy
- 5.1.3 Sleepwalking
- 5.1.4 Bruxism
- 5.1.5 Insomnia
- 5.1.6 Sleep apnea
- 5.2 Global Calming and Sleeping Market Size by Application
- 5.2.1 Global Calming and Sleeping Market Size Overview by Application (2021-2032)
- 5.2.2 Global Calming and Sleeping Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Calming and Sleeping Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Calming and Sleeping Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Calming and Sleeping Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Calming and Sleeping Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Calming and Sleeping Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Calming and Sleeping Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceutical
- 6.1.1 Teva Pharmaceutical Company Information
- 6.1.2 Teva Pharmaceutical Business Overview
- 6.1.3 Teva Pharmaceutical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceutical Calming and Sleeping Product Portfolio
- 6.1.5 Teva Pharmaceutical Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Calming and Sleeping Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Eli Lilly
- 6.3.1 Eli Lilly Company Information
- 6.3.2 Eli Lilly Business Overview
- 6.3.3 Eli Lilly Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Eli Lilly Calming and Sleeping Product Portfolio
- 6.3.5 Eli Lilly Recent Developments
- 6.4 AstraZeneca
- 6.4.1 AstraZeneca Company Information
- 6.4.2 AstraZeneca Business Overview
- 6.4.3 AstraZeneca Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 AstraZeneca Calming and Sleeping Product Portfolio
- 6.4.5 AstraZeneca Recent Developments
- 6.5 Sunovion Pharmaceuticals
- 6.5.1 Sunovion Pharmaceuticals Company Information
- 6.5.2 Sunovion Pharmaceuticals Business Overview
- 6.5.3 Sunovion Pharmaceuticals Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio
- 6.5.5 Sunovion Pharmaceuticals Recent Developments
- 6.6 Roscoe Medical
- 6.6.1 Roscoe Medical Company Information
- 6.6.2 Roscoe Medical Business Overview
- 6.6.3 Roscoe Medical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Roscoe Medical Calming and Sleeping Product Portfolio
- 6.6.5 Roscoe Medical Recent Developments
- 6.7 Durect
- 6.7.1 Durect Company Information
- 6.7.2 Durect Business Overview
- 6.7.3 Durect Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Durect Calming and Sleeping Product Portfolio
- 6.7.5 Durect Recent Developments
- 6.8 Collegium Pharmaceutical
- 6.8.1 Collegium Pharmaceutical Company Information
- 6.8.2 Collegium Pharmaceutical Business Overview
- 6.8.3 Collegium Pharmaceutical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Collegium Pharmaceutical Calming and Sleeping Product Portfolio
- 6.8.5 Collegium Pharmaceutical Recent Developments
- 6.9 Cara Therapeutics
- 6.9.1 Cara Therapeutics Company Information
- 6.9.2 Cara Therapeutics Business Overview
- 6.9.3 Cara Therapeutics Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Cara Therapeutics Calming and Sleeping Product Portfolio
- 6.9.5 Cara Therapeutics Recent Developments
- 6.10 Acura Pharmaceuticals
- 6.10.1 Acura Pharmaceuticals Company Information
- 6.10.2 Acura Pharmaceuticals Business Overview
- 6.10.3 Acura Pharmaceuticals Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Acura Pharmaceuticals Calming and Sleeping Product Portfolio
- 6.10.5 Acura Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Calming and Sleeping Sales by Country
- 7.1.1 North America Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Calming and Sleeping Sales by Country (2021-2026)
- 7.1.3 North America Calming and Sleeping Sales Forecast by Country (2027-2032)
- 7.2 North America Calming and Sleeping Market Size by Country
- 7.2.1 North America Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Calming and Sleeping Market Size by Country (2021-2026)
- 7.2.3 North America Calming and Sleeping Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Calming and Sleeping Sales by Country
- 8.1.1 Europe Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Calming and Sleeping Sales by Country (2021-2026)
- 8.1.3 Europe Calming and Sleeping Sales Forecast by Country (2027-2032)
- 8.2 Europe Calming and Sleeping Market Size by Country
- 8.2.1 Europe Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Calming and Sleeping Market Size by Country (2021-2026)
- 8.2.3 Europe Calming and Sleeping Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Calming and Sleeping Sales by Country
- 9.1.1 Asia-Pacific Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Calming and Sleeping Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Calming and Sleeping Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Calming and Sleeping Market Size by Country
- 9.2.1 Asia-Pacific Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Calming and Sleeping Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Calming and Sleeping Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Calming and Sleeping Sales by Country
- 10.1.1 South America Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Calming and Sleeping Sales by Country (2021-2026)
- 10.1.3 South America Calming and Sleeping Sales Forecast by Country (2027-2032)
- 10.2 South America Calming and Sleeping Market Size by Country
- 10.2.1 South America Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Calming and Sleeping Market Size by Country (2021-2026)
- 10.2.3 South America Calming and Sleeping Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Calming and Sleeping Sales by Country
- 11.1.1 Middle East and Africa Calming and Sleeping Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Calming and Sleeping Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Calming and Sleeping Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Calming and Sleeping Market Size by Country
- 11.2.1 Middle East and Africa Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Calming and Sleeping Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Calming and Sleeping Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Calming and Sleeping Value Chain Analysis
- 12.1.1 Calming and Sleeping Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Calming and Sleeping Production Mode & Process
- 12.2 Calming and Sleeping Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Calming and Sleeping Distributors
- 12.2.3 Calming and Sleeping Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst